|

Finerenone (Kerendia, BAY94-8862) Clinical Trials

3 actively recruiting trials across 1 location

▲ +2 trials since June 2026

Pipeline

Phase 3: 2

Top Sponsors

  • Bayer3

Indications

  • Heart Failure (Pediatric)2
  • Left Ventricular Systolic Dysfunction2
  • Heart Disease2
  • Type 2 Diabetes Mellitus1
  • Chronic Kidney Disease1

Aurora, Colorado2 trials

A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction

Children's Hospital Colorado - Anschutz Medical Campus - Cardiology

Phase 3
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction

Children's Hospital Colorado - Anschutz Medical Campus - Cardiology

Phase 3

Other1 trial

An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chronic Kidney Disease (CKD) Linked to Type 2 Diabetes, by Looking at Changes in a CKD Risk Score

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.